Recombinant Mouse Reactive oxygen species modulator 1 (Romo1)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Mouse Reactive Oxygen Species Modulator 1 (Romo1)

Recombinant Mouse Reactive Oxygen Species Modulator 1 (Romo1) is a mitochondrial membrane protein critical for regulating intracellular reactive oxygen species (ROS) production. Composed of 79 amino acids, it spans the mitochondrial inner membrane with two transmembrane domains (TMD1 and TMD2) and a cytosolic C-terminus . Its primary function involves modulating ROS levels by interacting with mitochondrial complexes and signaling pathways, influencing cellular processes such as proliferation, apoptosis, and immune response .

Amino Acid Sequence and Localization

Romo1’s sequence includes hydrophobic and polar regions:

  • TMD1: Hydrophobic α-helix (aa 1–40)

  • TMD2: Polar residues (K58, T59, Q62, S63, T66, T69) linked by a cytosolic loop

  • C-terminus: Interacts with mitochondrial proteins like Bcl-X L and TNF-α signaling complexes

PropertyDetails
Chromosomal Location20q11.22 (human homolog)
Subcellular LocalizationMitochondrial inner membrane
Molecular Weight~8.9 kDa (native), 11.0 kDa (recombinant with His-tag)

ROS Modulation and Signaling

Romo1 amplifies ROS production via mitochondrial complex III, influencing redox-sensitive pathways:

  • TNF-α Signaling: Interacts with TNF complex II (RIP1, TRADD, TRAF2) to trigger ROS-dependent apoptosis .

  • Bcl-X L Interaction: Disrupts mitochondrial membrane potential (Δψm), enhancing ROS leakage into the cytosol .

  • Cardiac Hypertrophy: Upregulates NF-κB via ROS, promoting stress-responsive cardiomyocyte growth .

Immune and Cancer Pathways

  • Macrophage Polarization: Overexpression promotes M2 polarization in glioblastoma via mTORC1 signaling, suppressing antitumor immunity .

  • Antibacterial Activity: Induces bacterial membrane disruption, as observed in S. aureus and M. tuberculosis .

Cancer Prognostics

Romo1 overexpression correlates with poor outcomes in multiple cancers:

Cancer TypeStudy FindingsSurvival Impact
NSCLCHigh expression predicts shorter PFS (13.1 vs 19.9 months) and OS (19.8 vs 37.0 months) HR = 3.17 for OS (95% CI: 1.57–6.41)
Colorectal CancerAssociated with lymph node metastasis and reduced DFS Cutoff H-score = 19 for unfavorable prognosis
GlioblastomaPromotes immune evasion via M2 macrophage polarization Tumor growth inhibition with Romo1 knockdown

Cardiovascular Disease

Romo1 knockdown prevents isoproterenol-induced cardiac hypertrophy by blocking ROS-NF-κB signaling .

Expression and Bioactivity

Recombinant Romo1 is produced in E. coli systems:

ParameterDetails
Purity≥85% (SDS-PAGE validated)
Antibacterial ActivityInhibits S. aureus and P. aeruginosa via membrane disruption
ROS InductionConfirmed via DCF-DA, MitoSOX, and DHE staining in macrophages

ROS Production in Macrophages

ConditionROS Levels (DHE Staining)Oxygen UptakeMitochondrial Proteins
Romo1 Overexpression↑ 2.5-fold vs control ↑ 40% ↑ ATP5A, MTCO1, UQCRC2
NAC Treatment↓ Rescue to baseline ↓ Rescue ↓ ATP5A, MTCO1, UQCRC2

Mitochondrial Complex Activity

ComplexActivity in Romo1−/− CellsImpact
IV↓ 40% Reduced Δψm (70% loss)
II↓ 40% Impaired respiration

Product Specs

Buffer
Lyophilized from Tris/PBS-based buffer containing 6% Trehalose.
Form
Available in both liquid and lyophilized powder formats.
Note: We will preferentially ship the format currently in stock. However, if you have a specific format preference, please indicate it in your order notes, and we will prepare according to your request.
Lead Time
3-7 business days
Notes
Repeated freeze-thaw cycles are not recommended. For optimal stability, store working aliquots at 4°C for up to one week.
Shelf Life
The shelf life of this product is dependent on various factors, including storage conditions, buffer composition, temperature, and the intrinsic stability of the protein.
Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
N-terminal 10xHis-tagged
Synonyms
Romo1; Reactive oxygen species modulator 1; ROS modulator 1; Protein MGR2 homolog
Datasheet & Coa
Please contact us to get it.
Expression Region
1-79aa
Mol. Weight
11.0 kDa
Protein Length
Full Length
Purity
Greater than 85% as determined by SDS-PAGE.
Research Area
Others
Source
in vitro E.coli expression system
Species
Mus musculus (Mouse)
Target Names
Romo1
Target Protein Sequence
MPVAVGPYGQSQPSCFDRVKMGFVMGCAVGMAAGALFGTFSCLRIGMRGRELMGGIGKTMMQSGGTFGTFMAIGMGIRC
Note: The complete sequence including tag sequence, target protein sequence and linker sequence could be provided upon request.
Uniprot No.

Target Background

Function
Romo1 exhibits antibacterial activity against a range of bacteria, including *Staphylococcus aureus*, *Pseudomonas aeruginosa*, and *Mycobacterium tuberculosis*. Its mechanism of action involves inducing bacterial membrane disruption. Furthermore, Romo1 stimulates the production of reactive oxygen species (ROS), which are essential for cell proliferation. It may also play a role in inducing oxidative DNA damage and replicative senescence. Additionally, Romo1 is implicated in regulating mitochondrial morphology and cell proliferation.
Database Links
Protein Families
MGR2 family
Subcellular Location
Mitochondrion inner membrane; Single-pass membrane protein.
Tissue Specificity
Detected in brain, liver and kidney.

Q&A

What is mouse Romo1 and what are its primary functions?

Mouse Reactive Oxygen Species Modulator 1 (Romo1) is a small mitochondrial protein that induces the production of reactive oxygen species (ROS) necessary for cell proliferation. It is primarily localized to the inner mitochondrial membrane and functions as a non-selective cation channel with structural similarities to class II viroporins. The protein plays crucial roles in regulating mitochondrial morphology, coordinating cell proliferation, and contributing to defense responses against bacteria . Romo1 belongs to the MGR2 family and contains approximately 79 amino acids. Its chromosomal location in humans (ortholog) is 20q11.22, and the protein is characterized by multiple biological processes including positive regulation of cell proliferation, defense response to bacteria, and replicative cell aging . Functionally, Romo1 serves as a critical molecular switch coupling metabolic stress to mitochondrial morphology, directly linking mitochondrial fusion to cell survival mechanisms .

How is Romo1 structurally organized and what technical challenges exist in its structural determination?

Mouse Romo1 possesses a complex structural organization that presents significant challenges for conventional structural analysis. The protein contains two transmembrane domains (TMDs), each consisting of an α-helix connected by a basic loop. TMD1 features a hydrophobic α-helix, while TMD2 comprises polar amino acids (K58, T59, Q62, S63, T66, and T69) individually separated by other amino acids, with 3.6 amino acids in each α-helical turn . Due to Romo1's small size and hydrophobic nature, researchers have been unable to determine its structure using X-ray crystallography or nuclear magnetic resonance (NMR) imaging methods . Instead, structural bioinformatics approaches have been employed to propose a hexameric model of Romo1 . The protein can form homo-oligomers in the mitochondrial inner membrane and functions as a hexameric, non-selective cation channel analogous to viroporins . When investigating recombinant Romo1, researchers should consider employing molecular dynamics simulations alongside experimental approaches, as direct structural determination remains technically challenging.

What are the primary experimental models for studying mouse Romo1 function?

Several experimental models have proven effective for investigating Romo1 function in research settings:

Model TypeAdvantagesLimitationsKey Applications
Cell Culture (Primary mouse cells)Direct physiological relevance, multiple cell types availableLimited lifespan, batch variabilityBasic functional studies, protein-protein interactions
Immortalized Mouse Cell LinesConsistency between experiments, unlimited supplyMay have altered signaling compared to primary cellsHigh-throughput screening, mechanistic studies
siRNA KnockdownTargeted reduction of Romo1 expressionTransient effect, potential off-target effectsPathway analysis, cell proliferation studies
CRISPR/Cas9 Gene EditingComplete knockout or precise mutationsMay be lethal due to Romo1's essential rolesDetailed functional characterization
Tissue HomogenatesPreserves tissue-specific contextComplex mixture of cell typesExpression analysis, activity assays

For gene knockdown studies, RNA interference techniques using siRNA directed against Romo1 have successfully inhibited the ERK pathway, which plays a key role in cell proliferation activated by Romo1-induced ROS . When designing experiments, researchers should carefully consider the cellular context, as Romo1 functions may vary between proliferating and senescent cells.

How does Romo1 regulate mitochondrial dynamics and morphology?

When investigating this aspect of Romo1 function, researchers should employ time-lapse confocal microscopy to visualize mitochondrial morphology changes in real-time following Romo1 modulation. Mitochondrial network analysis software can quantify parameters such as mitochondrial length, interconnectivity, and fragmentation. Co-immunoprecipitation assays are essential for identifying direct interactions between Romo1 and components of the mitochondrial dynamics machinery. The absence of Romo1 prevents proper OPA1 oligomerization, which damages the mitochondrial membrane and consequently leads to enhanced oxidative stress . This indicates that both insufficient and excessive Romo1 expression can disrupt mitochondrial homeostasis.

What methodological approaches are most effective for measuring Romo1-induced ROS production?

Accurate measurement of Romo1-induced ROS production requires multiple complementary techniques:

TechniquePrincipleAdvantagesConsiderations
DCFDA FluorescenceCell-permeable fluorogenic probe that measures hydroxyl, peroxyl and other ROSHigh sensitivity, suitable for live-cell imagingPotential artifacts, auto-oxidation issues
MitoSOX RedSelective detection of mitochondrial superoxideMitochondria-specific, compatible with flow cytometryRequires careful optimization of concentration
Lucigenin-enhanced ChemiluminescenceMeasures superoxide anion productionHigh specificity for superoxideLess suitable for subcellular localization
Electron Paramagnetic ResonanceDirect detection of unpaired electrons in free radicalsGold standard for ROS detection, highest specificityRequires specialized equipment, complex analysis
Genetically-encoded ROS SensorsExpression of redox-sensitive fluorescent proteinsReal-time monitoring, subcellular targeting possibleRequires transfection/transduction

When employing these techniques, researchers should include appropriate positive controls (e.g., treatment with known ROS inducers) and negative controls (antioxidants or ROS scavengers). Time-course experiments are essential as Romo1-induced ROS production may exhibit temporal dynamics. Additionally, combining ROS measurements with assessments of mitochondrial membrane potential provides valuable insights into the relationship between Romo1 activity and mitochondrial function. Research has shown that ROMO1 can decrease mitochondrial membrane potential through interactions with Bcl-XL, leading to ROS production and subsequent activation of c-Jun N-terminal kinase (JNK), ultimately inducing apoptotic cell death .

How does Romo1 interact with key signaling pathways in cellular proliferation and stress responses?

Romo1 exhibits complex interactions with multiple signaling pathways that regulate cellular proliferation and stress responses:

  • ERK Pathway: Romo1-induced ROS activates the extracellular signal-regulated kinases (ERK) pathway, promoting cell proliferation. RNA interference targeting Romo1 inhibits this pathway, confirming Romo1's regulatory role .

  • TGF-β Signaling: Romo1 affects the TGF-β pathway and associated factors including Smad2/3, extracellular matrix (ECM) proteins, and epithelial-mesenchymal transition (EMT) factors .

  • Wnt/β-catenin Pathway: Dickkopf1 (DKK1), an inhibitor of the Wnt/β-catenin pathway, affects Romo1 gene expression and inhibits its gene .

  • NF-κB Signaling: Romo1-induced ROS can control and decrease the inhibition of κB kinase (IKK), thereby activating the NF-κB pathway. This activation leads to the production of EMT factors such as SNAIL1, SNAIL2, and MMP2, which promote invasion and metastasis by damaging cell-to-cell connections and reducing cell adhesion .

  • Myc Regulation: Increased Myc enhances Romo1 expression, which in turn increases ROS production. Romo1-induced ROS causes the cytoplasmic translocation of Skp2, leading to Myc degradation through ubiquitylation. This positions Romo1 as a negative feedback regulator of Myc .

To investigate these interactions, researchers should employ phospho-specific antibodies for Western blotting, luciferase reporter assays, and chromatin immunoprecipitation (ChIP) to characterize transcriptional regulation. Co-expression studies using tagged proteins can help visualize subcellular localization and interactions.

What role does Romo1 play in cancer development and progression?

Romo1 was first reported in cancer tissue in 2006, where it was associated with drug resistance . As a regulator of ROS, Romo1 has been observed in various neoplastic cells and implicated in cancer invasion and progression . Several mechanisms underlie Romo1's oncogenic potential:

  • Cell Cycle Regulation: Romo1 activates the G2/M phase and reduces phospho-cdc2, promoting proliferation in cancer cells .

  • Drug Resistance: Increased expression of the Romo1 gene has been linked to cancer recurrence and resistance to chemotherapy, particularly to 5-FU . PCR analysis of tissues following chemotherapy has shown elevated Romo1 gene expression in recurring cancers .

  • NF-κB-Driven EMT: Romo1-induced ROS activates NF-κB, which increases the expression of EMT factors like SNAIL1, SNAIL2, and MMP2. These factors promote invasion and metastasis by disrupting cell adhesion .

  • Oxidative Stress: Excessive Romo1 expression increases ROS production, creating oxidative stress that contributes to cancer initiation and progression .

To study Romo1's role in cancer, researchers should:

  • Compare Romo1 expression in matched tumor and normal tissues using qPCR and immunohistochemistry

  • Correlate expression levels with clinical outcomes and treatment responses

  • Perform Romo1 knockdown/overexpression in cancer cell lines to assess effects on growth, invasion, and drug sensitivity

  • Use mouse xenograft models to evaluate Romo1's impact on tumor growth and metastasis in vivo

How does Romo1 contribute to cellular aging and senescence?

Romo1 plays a significant role in cellular aging through several interconnected mechanisms:

  • Oxidative DNA Damage: Romo1-induced ROS production contributes to oxidative DNA damage, a key driver of cellular senescence .

  • Replicative Senescence: Research indicates that Romo1 directly plays a role in replicative cell aging, suggesting it may serve as a molecular link between mitochondrial dysfunction and cellular senescence .

  • Mitochondrial Dysfunction: By affecting mitochondrial membrane integrity and dynamics, Romo1 dysregulation can accelerate age-related mitochondrial defects.

  • Inflammatory Signaling: Through its effects on NF-κB signaling, Romo1 may promote senescence-associated secretory phenotype (SASP), characterized by pro-inflammatory cytokine production.

For investigating Romo1's role in senescence, researchers should:

  • Compare Romo1 expression in young versus senescent cells using Western blotting and immunofluorescence

  • Assess senescence markers (SA-β-gal, p16, p21) following Romo1 modulation

  • Measure DNA damage using comet assays and γ-H2AX foci formation

  • Analyze telomere length and telomerase activity in relation to Romo1 expression

  • Evaluate mitochondrial function parameters including membrane potential, ATP production, and respiratory capacity

What is the role of Romo1 in inflammatory and immune responses?

Romo1 participates in several key inflammatory and immune processes:

  • Antimicrobial Activity: Romo1 demonstrates antimicrobial activity against various bacteria by inducing bacterial membrane breakage, suggesting a role in innate immunity .

  • NETs Formation: Romo1 contributes to neutrophil extracellular traps (NETs) formation, which are essential for fighting infectious agents. The scavenger receptor A (SRA) activates the ERK pathway, which in turn activates NADPH oxidase 2 (NOX2) and Romo1, increasing ROS production and leading to NETs formation .

  • TNF-α Signaling: Romo1 acts as a molecular mediator between TNF-α and the activation of apoptotic pathways. Components of complex II (FADD, TRADD, pro-caspase-8, TRAF2, RIP1) can bind to the C-terminal of Romo1. Subsequently, Romo1 uses Bcl-XL to decrease mitochondrial membrane potential, producing ROS that increases JNK activation and induces apoptotic cell death .

  • Matrix Metalloproteinases Regulation: Romo1 affects matrix metalloproteinases (MMPs), which play key roles in tissue regeneration and repair. MMPs activity can be regulated by ROS, which is increased through pathways involving Romo1 .

To investigate these aspects, researchers should design experiments that:

  • Assess bacterial killing efficiency in systems with modulated Romo1 expression

  • Measure NETs formation in neutrophils following Romo1 knockdown/overexpression

  • Analyze cytokine production and inflammatory signaling in various immune cell types

  • Evaluate tissue repair processes in models with altered Romo1 expression

What strategies can be employed to target Romo1 for potential therapeutic interventions?

Several approaches show promise for targeting Romo1 in therapeutic applications:

Targeting StrategyMechanismAdvantagesChallenges
Small Molecule InhibitorsDirect binding to Romo1 to alter functionHigh specificity potential, easier deliveryDifficult target due to mitochondrial localization
RNA InterferenceReduction of Romo1 expressionEstablished methodology, adjustable dosingDelivery to target tissues, potential off-target effects
Gene EditingPermanent modification of Romo1 geneLong-lasting effect, precisionEthical considerations, delivery challenges
Antioxidant TherapyCounteracting Romo1-induced ROSWell-established safety profilesNon-specific, may interfere with beneficial ROS signaling
Mitochondrial Dynamics ModulatorsIndirect targeting of Romo1 effectsAlternative approach when direct targeting failsComplex interactions, potential side effects

Research indicates that modulating Romo1 could potentially overcome drug resistance in cancer therapies, as increased Romo1 expression has been linked to resistance against chemotherapeutic agents such as 5-FU . Additionally, controlling Romo1-induced ROS might mitigate cancer progression by inhibiting EMT and metastasis through the NF-κB pathway .

When designing Romo1-targeted therapies, researchers should consider the dual nature of Romo1 function – both its absence and overexpression can lead to mitochondrial dysfunction and increased oxidative stress. Therefore, therapeutic modulation might need to restore balanced Romo1 activity rather than simply inhibiting it.

What are the most promising directions for future Romo1 research?

Future research on mouse Romo1 should focus on several high-priority areas:

  • Structural Biology: Developing improved methods for determining the precise structure of Romo1, potentially using cryo-electron microscopy combined with advanced computational approaches.

  • Tissue-Specific Functions: Investigating Romo1's role in different tissues and cell types, as its functions may vary considerably between proliferative tissues and post-mitotic cells.

  • Interaction Networks: Constructing comprehensive protein-protein interaction networks to better understand how Romo1 integrates into cellular signaling cascades.

  • Developmental Biology: Examining Romo1's role in embryonic development and tissue differentiation, which remains largely unexplored.

  • Comparative Biology: Investigating differences and similarities between mouse and human Romo1 to improve translational relevance of mouse model studies.

  • Environmental Influences: Studying how environmental factors such as pH affect Romo1 expression and function, as research has shown that acidic pH enhances Romo1 levels .

  • Role in Non-Cancer Pathologies: Expanding research beyond cancer to neurodegeneration, cardiovascular disease, and metabolic disorders, where ROS dysregulation plays significant roles.

Researchers should prioritize interdisciplinary approaches combining molecular biology, structural biology, systems biology, and translational research to fully elucidate Romo1's functions and therapeutic potential.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.